Stay updated on Avapritinib vs Regorafenib in GIST Clinical Trial
Sign up to get notified when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.

Latest updates to the Avapritinib vs Regorafenib in GIST Clinical Trial page
- Check2 days agoChange DetectedThe page now shows Revision: v3.7.0 in the Study Documents section, replacing Revision: v3.6.6, signaling an updated set of study documents.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, a minor metadata update that does not affect substantive study information.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page shows a new revision label, v3.6.5, replacing the previous v3.6.4. This indicates a deployment update to the site.SummaryDifference0.0%

- Check59 days agoChange DetectedA new page revision tag v3.6.4 was added and the previous v3.6.3 tag was removed, indicating a minor page update rather than content changes.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.3, signaling a new version of the page or its template; this is a technical update rather than a substantive modification to the study details.SummaryDifference0.0%

- Check95 days agoChange DetectedThe study page now displays a recruitment-closed notice ('No longer looking for participants') and adds user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the page revision tag to v3.6.0 and standardizes the Intervention/Treatment label.SummaryDifference0.2%

Stay in the know with updates to Avapritinib vs Regorafenib in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.